RURUS SURYAWAN Score: A Novel Scoring System to Predict 30-Day Mortality for Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
- PMID: 40095812
- PMCID: PMC11900541
- DOI: 10.3390/jcm14051716
RURUS SURYAWAN Score: A Novel Scoring System to Predict 30-Day Mortality for Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Abstract
Background/Objectives: It is essential to identify acute myocardial infarction patients with greater risk of deterioration following primary percutaneous coronary intervention. Due to an inconsistent result about predictors of 30-day outcomes regarding scoring systems for the first episode of acute myocardial infarction, the objective of this study is to develop novel scoring systems to predict 30-day mortality among patients with a first episode of acute myocardial infarction who underwent primary percutaneous coronary intervention. Methods: This retrospective study was conducted with total sampling for all patients with first-time acute myocardial infarction who underwent primary percutaneous coronary intervention between 2021 and 2024 at Dr. Soetomo Hospital, Indonesia. We performed a total sampling and collected 1714 patients, of which 1535 patients were included. Our primary outcomes included 30-day mortality. Results: The analysis included 1535 patients: 926 in the derivation set and 609 in the validation set. In our study, the 30-day mortality rate was 20.7%. Multivariate logistic regression analysis was used to build prediction models in the derivation group and then validated in the validation cohort. The area under the ROC curve of the RURUS SURYAWAN score to predict 30-day mortality was 0.944 (0.906-0.972) in the derivation set and 0.959 (0.921-0.983) in the validation set, with 94.6% sensitivity and 97.3% specificity (p < 0.001). Conclusions: After adjusting for potential confounders, we developed RURUS SURYAWAN, a novel scoring system to identify predictors of 30-day mortality among acute myocardial infarction before primary percutaneous coronary intervention.
Keywords: 30-day mortality; acute myocardial infarction; percutaneous coronary intervention; predictor.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
[Comparison of the predictive value of the modified CADILLAC, GRACE and TIMI risk scores for the risk of short-term death in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023 Mar;35(3):299-304. doi: 10.3760/cma.j.cn121430-20220727-00696. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 36916344 Chinese.
-
Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score.J Am Coll Cardiol. 2005 May 3;45(9):1397-405. doi: 10.1016/j.jacc.2005.01.041. J Am Coll Cardiol. 2005. PMID: 15862409
-
MELD-XI score predict no-reflow phenomenon and short-term mortality in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.BMC Cardiovasc Disord. 2022 Mar 18;22(1):113. doi: 10.1186/s12872-022-02556-2. BMC Cardiovasc Disord. 2022. PMID: 35300593 Free PMC article.
-
[Relationship between carbon dioxide combining power and contrast- induced acute kidney injury in patients with ST segment elevation myocardial infarction undergoing emergency percutaneous coronary intervention].Zhonghua Xin Xue Guan Bing Za Zhi. 2014 Jul;42(7):551-6. Zhonghua Xin Xue Guan Bing Za Zhi. 2014. PMID: 25327595 Chinese.
-
Development and Validation of a Novel Risk Score for Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.Cardiovasc Revasc Med. 2019 Nov;20(11):980-984. doi: 10.1016/j.carrev.2018.12.020. Epub 2018 Dec 27. Cardiovasc Revasc Med. 2019. PMID: 30773426
Cited by
-
Development and validation of an in-hospital major adverse cardiovascular events risk model for young patients with acute coronary syndrome: a retrospective cohort study.PeerJ. 2025 May 26;13:e19513. doi: 10.7717/peerj.19513. eCollection 2025. PeerJ. 2025. PMID: 40444287 Free PMC article.
References
-
- Widimsky P., Wijns W., Fajadet J., de Belder M., Knot J., Aaberge L., Andrikopoulos G., Baz J.A., Betriu A., Claeys M., et al. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: Description of the current situation in 30 countries. Eur. Heart J. 2010;31:943–957. doi: 10.1093/eurheartj/ehp492. - DOI - PMC - PubMed
-
- Yan F., Zhang Y., Pan Y., Li S., Yang M., Wang Y., Yanru C., Su W., Ma Y., Han L. Prevalence and associated factors of mortality after percutaneous coronary intervention for adult patients with ST-elevation myocardial infarction: A systematic review and meta-analysis. J. Res. Med. Sci. 2023;28:17. doi: 10.4103/jrms.jrms_781_21. - DOI - PMC - PubMed
-
- Kawamura Y., Yoshimachi F., Murotani N., Karasawa Y., Nagamatsu H., Kasai S., Ikari Y. Comparison of Mortality Prediction by the GRACE Score, Multiple Biomarkers, and Their Combination in All-comer Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Intern. Med. 2023;62:503–510. doi: 10.2169/internalmedicine.9486-22. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources